Keywords: ایمونوتراپی; Immunotherapy; Biomarkers; Hepatocellular; Pancreas; Gastric;
مقالات ISI ایمونوتراپی (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Keywords: ایمونوتراپی; Cancer heterogeneity; Cancer ecology and evolution; Immunoediting; Immunosuppression; Immunotherapy;
Keywords: ایمونوتراپی; Nanoparticles; Immunotoxicity; Immunotherapy; Drug delivery; Imaging;
Keywords: ایمونوتراپی; Radioactive iodine refractory differentiated thyroid cancer; Molecular imaging; Targeted chemotherapy; Gene therapy; Immunotherapy;
Keywords: ایمونوتراپی; Ammonio methacrylate copolymer nanoparticles; Pro-inflammatory cytokines and chemokines; Toll-like receptor 4; Immunotherapy; Cancer;
Keywords: ایمونوتراپی; Cancer stem cells; Immunogenicity; Immunotherapy; Prostate cancer stem cells; Stem cell genomics;
Keywords: ایمونوتراپی; Pancreatic cancer; Immunotherapy; Tumor associated antigen; PD-L1;
Keywords: ایمونوتراپی; Pancreatic cancer; Immunotherapy; Tumor microenvironment; Vaccines; Monoclonal antibodies;
Keywords: ایمونوتراپی; Melanoma; Metastasis; Brain; BRAF; Immunotherapy;
Keywords: ایمونوتراپی; Anal cancer; Clinical trials; Imaging; IMRT; Chemoradiotherapy; Immunotherapy;
Keywords: ایمونوتراپی; Breast cancer; Checkpoint inhibitor; Immunotherapy;
Keywords: ایمونوتراپی; Cancer stem cell; Drug resistance; Liposome; Drug delivery system; Clinical translation; Immunotherapy;
Keywords: ایمونوتراپی; Brain injury; Spinal cord injury; Innate and adaptive immunity; Inflammatory response; Immunotherapy; Secondary injury; APC; antigen-presenting cells; ASC; apoptosis-associated speck-like protein containing a carboxy-terminal CARD; BBB; blood-brain barrie
Keywords: ایمونوتراپی; Neuroblastoma; Targeted therapy; Investigational drugs; MYCN; ALK; Ras/MAPK; Clinical trial; Immunotherapy;
Keywords: ایمونوتراپی; Nanoparticles; Magnetic enrichment; Artificial antigen-presenting cells; T cells; Immunotherapy; Size;
Keywords: ایمونوتراپی; AP-1; activating protein 1; APC; antigen presenting cell; CAR; chimeric antigen receptors; Cbl-b; casitas B-lineage lymphoma; DAG; diacylglycerol; cSMAC; central supramolecular activation cluster; CTLA4; cytotoxic T lymphocyte antigen 4; dSMAC; distal sup
Keywords: ایمونوتراپی; Immunotherapy; Children; Farm; City; Improvement;
Keywords: ایمونوتراپی; venom peptides; targeted cancer therapy; immunotherapy; combinatorial anticancer drugs;
Keywords: ایمونوتراپی; Leukodystrophy; Vanishing white matter disease; EIF mutation; Cranial nerve enhancement; Immunotherapy;
Keywords: ایمونوتراپی; Androgen deprivation therapy; Castrate resistant; Immunotherapy; Nivolumab; Prostate cancer;
Keywords: ایمونوتراپی; Neoadjuvant; Immunotherapy; Head and neck cancer;
Keywords: ایمونوتراپی; Cocaine; Addiction; Monoclonal antibody; Immunotherapy; Master cell bank;
Keywords: ایمونوتراپی; Medulloblastoma; Cytomegalovirus; Cancer; Pediatric; Immunotherapy; APC; Adenomatous Polyposis Coli; CNS; Central Nervous System; COX-2; Cyclooxygenase-2; DC; Dendritic cell; GNPCs; Granule neuron precursor cells; HCMV; Human Cytomegalovirus; IL; Interleu
Keywords: ایمونوتراپی; Malignant mesothelioma; Pleural effusion; Immunotherapy; Tumor environment;
Keywords: ایمونوتراپی; Immune-related adverse event; Immunotherapy; Nivolumab; Non-small cell lung cancer; Psoriatic arthritis; Programmed cell death-1;
Keywords: ایمونوتراپی; Expression; High risk; Immunohistochemistry; Immunotherapy; Prostatic neoplasms;
Keywords: ایمونوتراپی; NSCLC; Immunotherapy; Adenocarcinoma; Nivolumab; Colitis; Pneumonitis; Pericarditis;
Keywords: ایمونوتراپی; Alpha-1 antitrypsin deficiency; Asthma; COPD; Emphysema; Screening for AATD; Diagnosis of AATD; Allergists; AATD; Alpha-1 antitrypsin deficiency; COPD; Chronic obstructive pulmonary disease; IT; Immunotherapy;
Keywords: ایمونوتراپی; Thrombotic thrombocytopenic purpura; Refractory disease; ADAMTS13; Rituximab; Immunotherapy;
Keywords: ایمونوتراپی; Apheresis; GVHD; haploidentical; immunotherapy; stem cell transplant;
Keywords: ایمونوتراپی; Opsoclonus-myoclonus syndrome; neuroblastoma; ataxia; immunotherapy;
Keywords: ایمونوتراپی; γc; common gamma chain, CD132; IL; interleukin; sγc; soluble form of common gamma chain; JAK; Janus-activated kinase; STAT; signal transducer and activator of transcription; T-ALL; T-cell acute lymphocytic leukemia; B-ALL; B-cell acute lymphocytic leuke
Keywords: ایمونوتراپی; Cancer; Immune infiltrate; Immunotherapy; Premalignant;
Keywords: ایمونوتراپی; Immunotherapy; Lung cancer; Immune checkpoint inhibitors; Inmunoterapia; Cáncer de pulmón; Inmunodesbloqueadores;
Keywords: ایمونوتراپی; Inmunoterapia; Cáncer de pulmón; Inmunodesbloqueadores; Immunotherapy; Lung cancer; Immune checkpoint inhibitors;
Keywords: ایمونوتراپی; Immunotherapy; Pembrolizumab; Nivolumab; First-line; Non-small cell lung cancer;
Keywords: ایمونوتراپی; Tumor immunology; Immunotherapy; T cells; CTLA4; PD-1;
Keywords: ایمونوتراپی; Allergy; Rhinitis; Immunotherapy; Asthma;
Keywords: ایمونوتراپی; Checkpoint inhibitors; Immunotherapy; Lymphocyte count; NSCLC; Response rate;
Keywords: ایمونوتراپی; Flavivirus; Ticks; Neutralizing antibodies; IVIG; Antibody-dependent enhancement; Immunotherapy;
Keywords: ایمونوتراپی; Immune checkpoint inhibitors; Immunotherapy; Immunosenescence; Aging; Immune aging; Older adults;
Keywords: ایمونوتراپی; bsAb; bispecific antibody; CAR; chimeric antigen receptor; CDN; cyclic dinucleotides; CTL; cytotoxic T lymphocyte; CTLA-4; cytotoxic T-lymphocyte-associated protein 4; GM-CSF; granulocyte-monocyte colony stimulating factor; IR; irradiation; PD-1; Programm
Keywords: ایمونوتراپی; Cancer; Chemotherapy; Effector cells; Immunotherapy; Multiple model predictive control;
Keywords: ایمونوتراپی; Aryl hydrocarbon receptor; AhR ligands; Immune-mediated diseases; Tregs; Immunotherapy;
Keywords: ایمونوتراپی; Synthetic biology; Cell-based device; Synthetic receptor; Immunotherapy; Robustness; Intercellular variation; CAR; Chimeric antigen receptor; GLP-1; Glucagon-like peptide-1; HEK; Human embryonic kidney; IL; Interleukin; iPSC; Induced pluripotent stem cell
Keywords: ایمونوتراپی; Prostate cancer; Tumor vaccine; Immunotherapy; PARP inhibitor; Checkpoint inhibitor;
Keywords: ایمونوتراپی; Renal cell carcinoma; Immunotherapy; Checkpoint inhibitors; Kidney cancer; Targeted therapy;
Keywords: ایمونوتراپی; Bladder cancer; Urothelial; Calmette-Guérin bacillus; Immunotherapy; Haematuria; Cystectomy; Tumor vesical; Urotelio; Bacilo Calmette-Guérin; Inmunoterapia; Hematuria; CistectomÃa;
Keywords: ایمونوتراپی; Metastatic renal-cell carcinoma; Second-line; Immunotherapy;
Keywords: ایمونوتراپی; Cancer; Hetero-isotherapy; Homeopathy; Immunotherapy; Tyrosine kinase inhibitor; Supportive care; Targeted therapy;